These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 8930462)

  • 61. Abrogation of anti-HLA antibodies via proteasome inhibition.
    Trivedi HL; Terasaki PI; Feroz A; Everly MJ; Vanikar AV; Shankar V; Trivedi VB; Kaneku H; Idica AK; Modi PR; Khemchandani SI; Dave SD
    Transplantation; 2009 May; 87(10):1555-61. PubMed ID: 19461494
    [TBL] [Abstract][Full Text] [Related]  

  • 62. HLA amino acid residue matching in 2575 kidney transplants.
    Tan J; Qiu J; Tang X
    Transplant Proc; 2007 Jun; 39(5):1429-31. PubMed ID: 17580154
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Arguments against HLA-A, -B, -DR mismatching in kidney transplant recipients.
    Cicciarelli J; Terasaki P
    Transplant Proc; 1989 Feb; 21(1 Pt 1):659-60. PubMed ID: 2650213
    [No Abstract]   [Full Text] [Related]  

  • 64. Association of kidney transplant failure and antibodies against MICA.
    Mizutani K; Terasaki P; Bignon JD; Hourmant M; Cesbron-Gautier A; Shih RN; Pei R; Lee J; Ozawa M
    Hum Immunol; 2006 Sep; 67(9):683-91. PubMed ID: 17002898
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Anti-HLA antibodies in kidney transplanted patients.
    Maccarone D; Cervelli C; Parzanese I; Pisani F; Caniglia L; Rascente M; Battistoni C; Famulari A; Adorno D
    Transplant Proc; 2005; 37(6):2459-60. PubMed ID: 16182708
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Kidney graft failure and presensitization against HLA class I and class II antigens.
    Süsal C; Opelz G
    Transplantation; 2002 Apr; 73(8):1269-73. PubMed ID: 11981420
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
    Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
    Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dissection of the respective importance of HLA-A,B,DR matching in 3,789 prospective kidney transplants.
    Hors J; Busson M; Bouteiller AM; Raffoux C; Betuel H; Fauchet R; Tongio MM; Mercier P; Lepetit JC; Dausset J
    Transplant Proc; 1987 Feb; 19(1 Pt 1):687-8. PubMed ID: 3274842
    [No Abstract]   [Full Text] [Related]  

  • 69. Interaction between panel reactive antibodies, auto- and cold reactive antibodies, and a positive B cell cross-match in renal and cardiac allograft survival.
    Creemers P; Brink J; Kahn D
    Clin Transplant; 1997 Apr; 11(2):134-8. PubMed ID: 9113450
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Influence of mismatching of HLA cross-reactive groups on cadaveric kidney transplantation.
    Hwang SH; Oh HB; Shin ES; Yew M; Kim SC; Han DJ
    Transplant Proc; 2005 Dec; 37(10):4194-8. PubMed ID: 16387076
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Patterns of "hidden" humoral allosensitization to HLA-A2 revealed by a simple modification of the standard lymphocytotoxic test.
    Bohinjec M; Vidan B
    Transplant Proc; 1992 Dec; 24(6):2497-501. PubMed ID: 1465844
    [No Abstract]   [Full Text] [Related]  

  • 72. Immunological profile of patients awaiting a renal transplant.
    Díaz I; Sánchez P; Alonso C; Valdés F
    Clin Transplant; 2004 Oct; 18(5):529-35. PubMed ID: 15344955
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Longitudinal testing of seventy-six renal allograft patients for HLA antibodies: Maastricht experience.
    van den Berg-Loonen EM; Terasaki P; Kohanof S; Christiaans MH
    Clin Transpl; 2006; ():305-22. PubMed ID: 18365386
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year follow-up.
    Lachmann N; Terasaki PI; Schönemann C
    Clin Transpl; 2006; ():171-99. PubMed ID: 18365377
    [TBL] [Abstract][Full Text] [Related]  

  • 75. T-cell flow-cytometry crossmatch and long-term renal graft survival.
    Rebibou JM; Bittencourt MC; Saint-Hillier Y; Chabod J; Dupont I; Bittard H; Chalopin JM; Hervé P; Tiberghien P
    Clin Transplant; 2004 Oct; 18(5):558-63. PubMed ID: 15344960
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report.
    Süsal C; Döhler B; Opelz G
    Hum Immunol; 2009 Aug; 70(8):569-73. PubMed ID: 19375472
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical relevance of complement-fixing antibodies in cardiac transplantation.
    Rose ML; Smith JD
    Hum Immunol; 2009 Aug; 70(8):605-9. PubMed ID: 19375471
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical relevance of low levels of preformed alloantibodies detected by flow cytometry in the first year post-kidney transplantation.
    Michelon T; Schroeder R; Fagundes I; Canabarro R; Sporleder H; Rodrigues H; Silveira J; Montagner J; Garcia V; Neumann J; Graudenz M
    Transplant Proc; 2005; 37(6):2750-2. PubMed ID: 16182800
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels.
    Issa N; Cosio FG; Gloor JM; Sethi S; Dean PG; Moore SB; DeGoey S; Stegall MD
    Transplantation; 2008 Sep; 86(5):681-5. PubMed ID: 18791449
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Impact of allocating cadaveric kidneys solely to "centers of excellence" versus by HLA matching.
    Gjertson DW; Takemoto S; Cecka JM; Terasaki PI
    Transplant Proc; 1995 Feb; 27(1):653-5. PubMed ID: 7879132
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.